January 8, 2026
HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to help restore blood flow in patients with peripheral artery disease (PAD). CIS interventional cardiologist and vascular specialist, Dr. Matthew Finn performed this procedure on December 22 at Terrebonne General Health System.
Developed by AngioSafe, the Santreva-ATK is the world’s first wire-free catheter designed to safely cross blocked or very narrow arteries in the upper legs and prepare them for treatment in a single step, using advanced technology to make the procedure more efficient – even in complex cases.
“The AngioSafe Santreva-ATK is an exciting new device for crossing arteries in the leg with 100% chronic blockages,” said Dr. Finn. “It allows for crossing of a very challenging lesion which would usually require additional access points and a longer procedure time.”
“Our partnership with CIS allows us to introduce leading-edge technology that elevates patient care,” said Phyllis Peoples, Terrebonne General President and CEO. “This achievement reflects our ongoing commitment to advancing services and ensuring our community has access to the highest level of cardiac care.”
PAD occurs when the peripheral arteries, most commonly in the legs, become narrowed and restrict blood flow. If left untreated, PAD increases the risk of heart attack and stroke and may progress to Critical Limb Ischemia (CLI), a severe form of artery blockage that significantly limits blood flow to the limbs and can lead to serious complications.
Click below to schedule an appointment at a CIS location near you.
Request an appointment today with a CIS cardiologist.